CLINICAL_TRIALS
withdrawal
· 2018-07-18
Clinical Trial Update: Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease [NA]
Summary
A clinical trial investigating bowel ultrasound for diagnosing necrotizing enterocolitis in patients with congenital heart disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Children's Mercy Hospital Kansas City | Conditions: Enterocolitis, Necrotizing, Congenital Heart Disease | NA | Status: WITHDRAWN